Parameters | PUL (n = 12) | TUEB (n = 12) | p value | Cohen’s d |
---|---|---|---|---|
Age (years), mean (SDc) | 71.8 (6.4) | 71.1 (7.5) | 0.8 | 0.095 |
Prostate volume (ml), median (IQRd) | 59.5 (39.5–65) | 63.5 (41.7–66.6) | 0.5 | - |
Number of Charlson Comorbidity Index score 1 or more (%) | 4 (33) | 5 (41) | 0.6 | - |
Preoperative | ||||
MFRe (ml/s), mean (SD) | 7.4 (4) | 7.3 (2.3) | 0.9 | -0.31 |
PVRf (ml), mean (SD) | 102.5 (158.8) | 253.8 (312.8) | 0.15 | 0.62 |
Urine volume, mean (SD) | 75.6 (50.3) | 192.4 (129.5) | 0.01 | 1.26 |
IPSSg Q1, mean (SD) | 3.2 (1.8) | 3.6 (1.2) | 0.6 | 0.22 |
IPSS Q2, mean (SD) | 2.6 (1.7) | 3.8 (1.6) | 0.13 | 0.66 |
IPSS Q3, mean (SD) | 2.9 (2.0) | 2.9 (1.9) | 0.9 | –0.008 |
IPSS Q4, mean (SD) | 1.6 (1.4) | 2.1 (1.9) | 0.5 | 0.25 |
IPSS Q5, mean (SD) | 3.6 (1.6) | 4.4 (0.9) | 0.23 | 0.52 |
IPSS Q6, mean (SD) | 1.8 (1.7) | 2.3 (1.8) | 0.5 | 0.25 |
IPSS Q7, mean (SD) | 2.5 (1.3) | 2.6 (1.2) | 0.9 | 0.13 |
Total IPSS, mean (SD) | 18.5 (8.5) | 18 (10.2) | 0.8 | -0.53 |
Operative time (minutes), median (IQR) | 14 (11.2–21) | 138.5 (124.2–153.5) | < 0.001 | – |
Postoperative | ||||
MFR (ml/s), mean (SD) | 12.5 (2.9) | 15.1 (5.6) | 0.18 | –0.59 |
PVR (ml), mean (SD) | 43.2 (51.3) | 88 (91.9) | 0.16 | –0.6 |
Urine volume, mean (SD) | 180.8 (40.5) | 154.9 (104.8) | 0.4 | 0.33 |
IPSS Q1, mean (SD) | 1.5 (1.3) | 0.8 (0.9) | 0.18 | 0.58 |
IPSS Q2, mean (SD) | 1.8 (1.1) | 1.4 (1.0) | 0.3 | 0.38 |
IPSS Q3, mean (SD) | 1.5 (1.4) | 0.8 (1.6) | 0.2 | 0.45 |
IPSS Q4, mean (SD) | 1.2 (1.2) | 0.6 (0.5) | 0.13 | 0.67 |
IPSS Q5, mean (SD) | 1.7 (1.5) | 0.6 (0.6) | 0.042 | 0.92 |
IPSS Q6, mean (SD) | 0.9 (1.4) | 0.2 (0.6) | 0.16 | 0.62 |
IPSS Q7, mean (SD) | 2 (1.2) | 1.8 (0.7) | 0.6 | 0.18 |
Total IPSS, mean (SD) | 10.7 (6.7) | 5.5 (4.1) | 0.035 | 0.91 |